Treatment of stage I seminoma

ISRCTN	ISRCTN54221666
DOI	https://doi.org/10.1186/ISRCTN54221666
Protocol serial number	TE10
Sponsor	Medical Research Council (MRC) (UK)
Funder	Medical Research Council (MRC) (UK)

Prospectively registered

Protocol

Statistical analysis plan

Results

Individual participant data

Plain English summary of protocol

Not provided at time of registration

Miss Sharon Naylor
Scientific

MRC Clinical Trials Unit
222 Euston Road
London
NW1 2DA
United Kingdom

Primary study design	Interventional
Study design	Randomised controlled trial
Secondary study design	Randomised controlled trial
Scientific title
Study objectives	To define the optimum field size for administration of radiotherapy
Ethics approval(s)	Not provided at time of registration.
Health condition(s) or problem(s) studied	Cancer
Intervention	Two arms both receive 30 Gy in 15 fractions radiotherapy. Arm 1: Para-aortic strip field Arm 2: Dog led field
Intervention type	Other
Primary outcome measure(s)	Pelvic recurrence rate
Key secondary outcome measure(s)	Not provided at time of registration
Completion date	31/12/1993

Participant type(s)	Patient
Age group	Not Specified
Sex	Male
Target sample size at registration	478
Key inclusion criteria	Stage I disease, histologically confirmed seminomatous germ cell tumour
Key exclusion criteria	Patients with previous ipsilateral inguinal operations.
Date of first enrolment	01/03/1989
Date of final enrolment	31/12/1993

MRC Clinical Trials Unit

London
NW1 2DA
United Kingdom

Individual participant data (IPD) Intention to share	No
IPD sharing plan summary	Not provided at time of registration
IPD sharing plan

Output type	Details	Date created	Date added	Peer reviewed?	Patient-facing?
Results article	results	01/04/1999		Yes	No